Search Results Search Sort by RelevanceMost Recent Case and Commentary Oct 2022 How Should Biocontainment Balance Infection Control With Practice Sustainability? Abigail E. Lowe, MA, Aurora B. Le, PhD, MPH, CSP, CPH, and Shawn G. Gibbs, PhD, MBA, CIH Human health promotion and environmental protection are values that sometimes complement each other, but sometimes conflict in BCU management. AMA J Ethics. 2022;24(10):E944-950. doi: 10.1001/amajethics.2022.944. Case and Commentary Dec 2004 A Fever of Unknown Source, Commentary 1 Francis A. Neelon, MD Virtual Mentor. 2004;6(12):529-531. doi: 10.1001/virtualmentor.2004.6.12.ccas1-0412. Case and Commentary Dec 2004 A Fever of Unknown Source, Commentary 2 Robert H. Pantell, MD Virtual Mentor. 2004;6(12):531-533. doi: 10.1001/virtualmentor.2004.6.12.ccas1-0412. Case and Commentary Dec 2004 A Fever of Unknown Source, Commentary 3 Timothy E. Quill, MD Virtual Mentor. 2004;6(12):533-535. doi: 10.1001/virtualmentor.2004.6.12.ccas1-0412. Case and Commentary Feb 2024 How Should Wet Market Practices Be Regulated to Curb Zoonotic Disease Transmission? Jake Young, PhD, MPH, MFA Consumption and trade of wild animals present major zoonotic disease transmission risks. AMA J Ethics. 2024;26(2):E116-121. doi: 10.1001/amajethics.2024.116. Case and Commentary Dec 2009 The Challenges of Treating Patients with Multiple Diagnoses R. Douglas Bruce, MD, MA, MSc Strategies for designing treatment programs for patients with triple diagnoses—HIV, schizophrenia, and opioid dependence. Virtual Mentor. 2009;11(12):944-948. doi: 10.1001/virtualmentor.2009.11.12.ccas3-0912. Case and Commentary May 2024 Should Antimicrobial Resistance Limit Access to an Organ Transplant? Andrew Courtwright, MD, PhD This article discusses fiduciary obligations transplant programs might have to patients with B cenocepacia. AMA J Ethics. 2024;26(5):E367-372. doi: 10.1001/amajethics.2024.367.
Case and Commentary Oct 2022 How Should Biocontainment Balance Infection Control With Practice Sustainability? Abigail E. Lowe, MA, Aurora B. Le, PhD, MPH, CSP, CPH, and Shawn G. Gibbs, PhD, MBA, CIH Human health promotion and environmental protection are values that sometimes complement each other, but sometimes conflict in BCU management. AMA J Ethics. 2022;24(10):E944-950. doi: 10.1001/amajethics.2022.944.
Case and Commentary Dec 2004 A Fever of Unknown Source, Commentary 1 Francis A. Neelon, MD Virtual Mentor. 2004;6(12):529-531. doi: 10.1001/virtualmentor.2004.6.12.ccas1-0412.
Case and Commentary Dec 2004 A Fever of Unknown Source, Commentary 2 Robert H. Pantell, MD Virtual Mentor. 2004;6(12):531-533. doi: 10.1001/virtualmentor.2004.6.12.ccas1-0412.
Case and Commentary Dec 2004 A Fever of Unknown Source, Commentary 3 Timothy E. Quill, MD Virtual Mentor. 2004;6(12):533-535. doi: 10.1001/virtualmentor.2004.6.12.ccas1-0412.
Case and Commentary Feb 2024 How Should Wet Market Practices Be Regulated to Curb Zoonotic Disease Transmission? Jake Young, PhD, MPH, MFA Consumption and trade of wild animals present major zoonotic disease transmission risks. AMA J Ethics. 2024;26(2):E116-121. doi: 10.1001/amajethics.2024.116.
Case and Commentary Dec 2009 The Challenges of Treating Patients with Multiple Diagnoses R. Douglas Bruce, MD, MA, MSc Strategies for designing treatment programs for patients with triple diagnoses—HIV, schizophrenia, and opioid dependence. Virtual Mentor. 2009;11(12):944-948. doi: 10.1001/virtualmentor.2009.11.12.ccas3-0912.
Case and Commentary May 2024 Should Antimicrobial Resistance Limit Access to an Organ Transplant? Andrew Courtwright, MD, PhD This article discusses fiduciary obligations transplant programs might have to patients with B cenocepacia. AMA J Ethics. 2024;26(5):E367-372. doi: 10.1001/amajethics.2024.367.